The COVID-19 vaccine developed by Oxford University and AstraZeneca was 79% effective in preventing symptomatic illness a large trial in the United States, Chile and Peru, the company said on Monday,...
https://ift.tt/eA8V8J
https://ift.tt/eA8V8J
Comments
Post a Comment